Craft

Lifeward

Stock Price

$2.4

2024-10-29

Market Capitalization

$20.7 M

2024-10-29

Revenue

$22 M

FY, 2025

Lifeward Summary

Company Summary

Overview
Lifeward (לייפווארד בע"מ, formerly known as ReWalk Robotics, ריווק רובוטיקס בע"מ) is a medical device company that designs, develops, and commercializes walking systems for people with lower limb disabilities. Its products include ReWalk Personal Exoskeleton for patients with spinal cord injuries; ReStore, a powered, lightweight soft exo-suit intended for use during the rehabilitation of individuals with lower limb disabilities due to stroke; and AlterG Anti-Gravity Treadmill that enables patients and athletes to move unrestricted and pain-free during rehabilitation and training. The company also retails MYOLYN Functional Electrical Stimulation (FES) bikes that provide therapeutic cycling for both clinic and home use.
Type
Public
Status
Active
Founded
2001
HQ
Yokne'am Illit, IL | view all locations
Website
https://golifeward.com/
Cybersecurity rating
Sectors

Key People

  • Miri Pariente

    Miri Pariente, Vice President of Operations, Regulatory and Quality

  • Jeannine Lynch

    Jeannine Lynch, Vice President of Strategy and Market Access

  • Judy Kula

    Judy Kula, Vice President of Customer Service, Human Resources and Business Affairs

  • David Hexner

    David Hexner, Vice President of Research and Development

Operating MetricsView all

Facilities Leased, sq. ft.

24.1K

FY, 2021

Rehabilitation Units Placed to Date

121
1.7%

FY, 2021

Personal Units Placed to Date

533
8.3%

FY, 2021

LocationsView all

4 locations detected

  • Yokne'am Illit, North District HQ

    Israel

    3 Hatnufa St., 6th floor, P.O. Box 161

  • Fremont, CA

    United States

    48368 Milmont Dr

  • Marlborough, MA

    United States

    200 Donald Lynch Blvd.

  • Berlin, Berlin

    Germany

    15 Leipziger Pl.

Lifeward Financials

Summary Financials

Revenue (FY, 2025)
$22.0M
Gross profit (FY, 2025)
$8.4M
Net income (FY, 2025)
($19.9M)
Cash (FY, 2025)
$2.2M
EBIT (FY, 2025)
($19.7M)
Enterprise value
$22.9M

Footer menu